Correlation between mRNAseq expression and clinical features

Glioblastoma Multiforme (Primary solid tumor)

15 July 2014 | analyses__2014_07_15

Maintainer Information

Citation Information

Maintained by Juok Cho (Broad Institute)

Cite as Broad Institute TCGA Genome Data Analysis Center (2014): Correlation between mRNAseq expression and clinical features. Broad Institute of MIT and Harvard. doi:10.7908/C10C4TH1

Overview

Introduction

This pipeline uses various statistical tests to identify mRNAs whose log2 expression levels correlated to selected clinical features.

Summary

Testing the association between 18210 genes and 7 clinical features across 152 samples, statistically thresholded by P value < 0.05 and Q value < 0.3, 3 clinical features related to at least one genes.

4 genes correlated to 'AGE'.

LOC84856|84856 , CBARA1|10367 , NOL3|8996 , SSH3|54961

5 genes correlated to 'GENDER'.

CYORF15A|246126 , HDHD1A|8226 , NCRNA00183|554203 , CYORF15B|84663 , FRG1B|284802

7 genes correlated to 'RADIATIONS.RADIATION.REGIMENINDICATION'.

ZNF677|342926 , LOC80054|80054 , SP3|6670 , IPO7|10527 , TIAF1|9220 , ...

No genes correlated to 'Time to Death', 'KARNOFSKY.PERFORMANCE.SCORE', 'RACE', and 'ETHNICITY'.

Results

Overview of the results

Complete statistical result table is provided in Supplement Table 1

Table 1. Get Full Table This table shows the clinical features, statistical methods used, and the number of genes that are significantly associated with each clinical feature at P value < 0.05 and Q value < 0.3.

Clinical feature	Statistical test	Significant genes	Associated with		Associated with
Time to Death	Cox regression test	N=0
AGE	Spearman correlation test	N=4	older	N=2	younger	N=2
GENDER	Wilcoxon test	N=5	male	N=5	female	N=0
KARNOFSKY PERFORMANCE SCORE	Spearman correlation test	N=0
RADIATIONS RADIATION REGIMENINDICATION	Wilcoxon test	N=7	yes	N=7	no	N=0
RACE	Kruskal-Wallis test	N=0
ETHNICITY	Wilcoxon test	N=0

Clinical variable #1: 'Time to Death'

No gene related to 'Time to Death'.

Table S1. Basic characteristics of clinical feature: 'Time to Death'


Time to Death	Duration (Months)	0.2-54 (median=9.1)
	censored	N = 35
	death	N = 117

	Significant markers	N = 0

Clinical variable #2: 'AGE'

4 genes related to 'AGE'.

Table S2. Basic characteristics of clinical feature: 'AGE'


AGE	Mean (SD)	59.74 (14)
	Significant markers	N = 4
	pos. correlated	2
	neg. correlated	2

List of 4 genes differentially expressed by 'AGE'

Table S3. Get Full Table List of 4 genes significantly correlated to 'AGE' by Spearman correlation test

	SpearmanCorr	corrP	Q
LOC84856\|84856	-0.3698	3.461e-06	0.063
CBARA1\|10367	-0.3613	4.793e-06	0.0873
NOL3\|8996	0.3484	1.087e-05	0.198
SSH3\|54961	0.3481	1.112e-05	0.202

Clinical variable #3: 'GENDER'

5 genes related to 'GENDER'.

Table S4. Basic characteristics of clinical feature: 'GENDER'


GENDER	Labels	N
	FEMALE	53
	MALE	99

	Significant markers	N = 5
	Higher in MALE	5
	Higher in FEMALE	0

List of 5 genes differentially expressed by 'GENDER'

Table S5. Get Full Table List of 5 genes differentially expressed by 'GENDER'. 24 significant gene(s) located in sex chromosomes is(are) filtered out.

	W(pos if higher in 'MALE')	wilcoxontestP	Q	AUC
CYORF15A\|246126	3465	1.748e-18	3.18e-14	1
HDHD1A\|8226	614	8.019e-15	1.46e-10	0.883
NCRNA00183\|554203	625	1.121e-14	2.04e-10	0.8809
CYORF15B\|84663	2376	3.492e-14	6.35e-10	1
FRG1B\|284802	3743	1.516e-05	0.276	0.7134

Clinical variable #4: 'KARNOFSKY.PERFORMANCE.SCORE'

No gene related to 'KARNOFSKY.PERFORMANCE.SCORE'.

Table S6. Basic characteristics of clinical feature: 'KARNOFSKY.PERFORMANCE.SCORE'


KARNOFSKY.PERFORMANCE.SCORE	Mean (SD)	75.75 (14)
	Significant markers	N = 0

Clinical variable #5: 'RADIATIONS.RADIATION.REGIMENINDICATION'

7 genes related to 'RADIATIONS.RADIATION.REGIMENINDICATION'.

Table S7. Basic characteristics of clinical feature: 'RADIATIONS.RADIATION.REGIMENINDICATION'


RADIATIONS.RADIATION.REGIMENINDICATION	Labels	N
	NO	102
	YES	50

	Significant markers	N = 7
	Higher in YES	7
	Higher in NO	0

List of 7 genes differentially expressed by 'RADIATIONS.RADIATION.REGIMENINDICATION'

Table S8. Get Full Table List of 7 genes differentially expressed by 'RADIATIONS.RADIATION.REGIMENINDICATION'

	W(pos if higher in 'YES')	wilcoxontestP	Q	AUC
ZNF677\|342926	1332	1.801e-06	0.0328	0.7388
LOC80054\|80054	3703	6.195e-06	0.113	0.7261
SP3\|6670	1423	9.978e-06	0.182	0.721
IPO7\|10527	1436	1.262e-05	0.23	0.7184
TIAF1\|9220	3663	1.284e-05	0.234	0.7182
CEMP1\|752014	3658	1.405e-05	0.256	0.7173
LPCAT4\|254531	3652	1.563e-05	0.285	0.7161

Clinical variable #6: 'RACE'

No gene related to 'RACE'.

Table S9. Basic characteristics of clinical feature: 'RACE'


RACE	Labels	N
	ASIAN	5
	BLACK OR AFRICAN AMERICAN	10
	WHITE	136

	Significant markers	N = 0

Clinical variable #7: 'ETHNICITY'

No gene related to 'ETHNICITY'.

Table S10. Basic characteristics of clinical feature: 'ETHNICITY'


ETHNICITY	Labels	N
	HISPANIC OR LATINO	3
	NOT HISPANIC OR LATINO	125

	Significant markers	N = 0

Methods & Data

Input

Expresson data file = GBM-TP.uncv2.mRNAseq_RSEM_normalized_log2.txt
Clinical data file = GBM-TP.merged_data.txt
Number of patients = 152
Number of genes = 18210
Number of clinical features = 7

Survival analysis

For survival clinical features, Wald's test in univariate Cox regression analysis with proportional hazards model (Andersen and Gill 1982) was used to estimate the P values using the 'coxph' function in R. Kaplan-Meier survival curves were plot using the four quartile subgroups of patients based on expression levels

Correlation analysis

For continuous numerical clinical features, Spearman's rank correlation coefficients (Spearman 1904) and two-tailed P values were estimated using 'cor.test' function in R

Student's t-test analysis

For two-class clinical features, two-tailed Student's t test with unequal variance (Lehmann and Romano 2005) was applied to compare the log2-expression levels between the two clinical classes using 't.test' function in R

ANOVA analysis

For multi-class clinical features (ordinal or nominal), one-way analysis of variance (Howell 2002) was applied to compare the log2-expression levels between different clinical classes using 'anova' function in R

Q value calculation

For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.

Download Results

In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.

References

[1] Andersen and Gill, Cox's regression model for counting processes, a large sample study, Annals of Statistics 10(4):1100-1120 (1982)

[2] Spearman, C, The proof and measurement of association between two things, Amer. J. Psychol 15:72-101 (1904)

[3] Lehmann and Romano, Testing Statistical Hypotheses (3E ed.), New York: Springer. ISBN 0387988645 (2005)

[4] Howell, D, Statistical Methods for Psychology. (5th ed.), Duxbury Press:324-5 (2002)

[5] Benjamini and Hochberg, Controlling the false discovery rate: a practical and powerful approach to multiple testing, Journal of the Royal Statistical Society Series B 59:289-300 (1995)

Made with Nozzle